Subtypes of Major Depression as Targets of Drug Development
Dr. Schatzberg is the Kenneth T. Norris, Jr., Professor in the Department of Psychiatry and Behavioral Sciences at Stanford Universtiy, and Director of the Stanford Mood Disorders Center. Dr. Schatzberg has been an active investigator in the biology and psychopharmacology of depressive disorders, exploring: norepinephrine systems in depression as a means of subtyping these disorders, the biological mechanisms
that underlie the development of delusions in major depression and innovative therapeutic strategies; and the clinical psychopharmacology of nondelusional depression with a particular interest in chronic depression and pharmocogenetics. He has authored over 700 publications and abstracts, including the Manual of Clinical Psychopharmacology, whose eighth edition appeared in 2015 and which is co-authored by Dr. Charles DeBattista. He also co-edited with Dr. Charles B. Nemeroff the Textbook of Psychopharmacology whose fifth edition is in press. He is Co-Editor-in-Chief of the Journal of Psychiatric Research and sits on many other editorial boards as well, including Journal of Clinical Psychopharmacology, Psychoneuroendocrinology, Biological Psychiatry, and others. He is a Past President of the American Psychiatric Association, American College of Neuropsychopharmacology (ACNP) and the Society of Biological Psychiatry (SOBP) and was also the Secretary-General of the International Society of Psychoneuroendocrinology.